EUVIMEDEUVIMED entdecken
Crossref

Abstract 4262: Risk of Deep Vein Thrombosis Following Use of Vascular Closure Devices in Electrophysiology Procedures

Abstract 4262: Risiko für tiefe Venenthrombose nach Einsatz von Gefäßverschlussgeräten bei elektrophysiologischen Eingriffen

Thomas Truglio, Yong Zhao, Mounica Yanamandala, Emily P Zeitler

Circulation · 02.11.2026 · 154 (Suppl_1)

DOI: 10.1161/circ.154.suppl_1.4262 ↗

Auf einen Blick

Bei 177.982 Patient:innen war der Einsatz von VCDs nach nicht-AF-EP-Eingriffen mit mehr DVT/PE verbunden. Bei AF-Ablation zeigte sich kein Unterschied.

Fragestellung

Ist der Einsatz von Vascular Closure Devices nach nicht-AF-EP-Eingriffen mit einem erhöhten Risiko für DVT/PE verbunden?

Methode

Analyse von Truveta-Daten zu erwachsenen Patient:innen mit EP-Eingriffen 2020-2025; multivariate logistische Regression; Outcome DVT/PE innerhalb von 30 Tagen.

Ergebnisse

177.982 Patient:innen; 25,1 % erhielten VCDs. DVT/PE: 0,76 % mit VCD vs. 0,65 % ohne VCD. Adjustierte OR gesamt 1,22 (95 %-KI 1,07–1,38); nicht-AF 1,51 (1,25–1,80); AF 1,07 (0,90–1,29).

Schlussfolgerung der Autor:innen

Bei realer Versorgung war VCD-Nutzung nach nicht-AF-EP-Ablationsverfahren mit erhöhtem DVT/PE-Risiko verbunden. Die Autor:innen sehen prospektive Studien zu thrombotischen Outcomes als notwendig an.

Kernaussagen

  • DVT/PE insgesamt: 0,76 % mit VCD vs. 0,65 % ohne VCD
  • Nicht-AF: aOR 1,51 (95 %-KI 1,25–1,80)
  • AF-Gruppe: kein Unterschied (aOR 1,07; 95 %-KI 0,90–1,29)

Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.

Kurz gefasst

Fachartikel in der Zeitschrift Circulation, erschienen am 02.11.2026. Verfasst von Thomas Truglio und 3 weiteren Autor:innen.

Auf einen BlickAbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Vascular closure devices (VCDs) are commonly used following femoral venous access during electrophysiology (EP) procedures with most of the supporting evidence for use being from atrial fibrillation (AF) ablation procedures. Limited studies suggest that arterial VCDs are associated with an increased risk for venous thrombosis. As such, the associated risk of thrombosis in non-AF ablation EP procedures when patients are not routinely anticoagulated has not been evaluated. Furthermore, VCDs employ a variety of mechanisms of action, and the comparative outcomes from these devices has not been reported. Hypothesis: VCDs are associated with an increased risk of the combined endpoint of deep venous thrombosis (DVT) and pulmonary embolism (PE) following non-AF ablation EP procedures.

Methods

The analysis cohort was identified from the Truveta database; a health record database from over 30 health systems and 130 million up to date patient records. The cohort Included adult patients with an EP procedure (2020-2025) based on CPT codes. The primary outcome was incidence of DVT or PE within 30 days of the EP procedure identified via ICD-10 diagnosis codes. Multivariate logistic regression was used to compare the risk of DVT/PE between groups with and without VCD and within the subgroups of patients who had an AF ablation versus a non-AF ablation EP procedure. Procedure related bleeding was assessed within groups based on relevant CPT and ICD-10 diagnosis codes.

Results

The cohort included 177,982 patients (mean age 66.6±13.0 39.7% female). Over half of procedures were AF ablation (n=107,001, 60.1%). VCDs were used in 25.1% of cases overall (n=44,702)(Table 1). VCD use increased over the study period (Figure 1). The overall rate of DVT/PE was low: 0.76% in the VCD group (0.56% - AF ablation; 1.1% - non-AF ablation) and 0.65% in the non-VCD group (0.56% - AF ablation, 0.77% - non-AF ablation). VCDs were associated with a higher rate of DVT/PE overall (adjusted odds ratio [aOR] 1.22, 95% CI 1.07-1.38) and in the subgroup of non-AF procedures (aOR 1.51 95% CI 1.25-1.80). In the AF subgroup, there was no difference in the odds of DVT/PE with VCDs (aOR 1.07 95%CI 0.90-1.29). All VCD subtypes were associated with increased odds of DVT/PE in non-AF ablation procedures (Figure 2). There was no significant difference in procedure-related bleeding with and without VCD use (2.0% vs 1.8% p=0.09).

Conclusion

In a real-world population, VCD use is associated with an increased risk of DVT/PE following non-AF EP ablation procedures for which chronic therapeutic anticoagulation is not standard. Increased thrombotic risk was seen with all VCD subtypes, suggesting the risk is not unique to one mechanism of closure. Given the expanding use of VCDs in EP procedures, prospective evaluation of thrombotic outcomes is needed. The risks of routine VCD use in high-risk patients may outweigh benefits.

Zitieren

APA

Truglio, T., Zhao, Y., Yanamandala, M., & Zeitler, E. P. (2026). Abstract 4262: Risk of Deep Vein Thrombosis Following Use of Vascular Closure Devices in Electrophysiology Procedures. Circulation, 154(Suppl_1). https://doi.org/10.1161/circ.154.suppl_1.4262

Vancouver

Truglio T, Zhao Y, Yanamandala M, Zeitler EP. Abstract 4262: Risk of Deep Vein Thrombosis Following Use of Vascular Closure Devices in Electrophysiology Procedures. Circulation. 2026;154(Suppl_1). doi:10.1161/circ.154.suppl_1.4262

BibTeX
@article{Truglio2026,
  author = {Truglio, Thomas and Zhao, Yong and Yanamandala, Mounica and Zeitler, Emily P},
  title = {Abstract 4262: Risk of Deep Vein Thrombosis Following Use of Vascular Closure Devices in Electrophysiology Procedures},
  journal = {Circulation},
  year = {2026},
  volume = {154},
  number = {Suppl_1},
  doi = {10.1161/circ.154.suppl_1.4262}
}
Kostenlos starten →